Yves Leurquin

Co-CEO at Inventprise

Yves Leurquin leads partnerships, capital formation and structural growth at Inventprise. Before joining Inventprise, Yves Leurquin was Global Head of Pricing and Tender Management for Takeda’s Vaccine Business Unit. He joined the newly created Takeda Vaccine Business Unit at its inception where he led the Asia Pacific Region and then the European Region. Yves also held corporate board positions, at Takeda Vaccine Internationals. Additionally, Yves prior experience included EVP International and Government Affairs at Johnson & Johnson (Crucell) with oversight of relations with the United Nations organizations as well as business responsibility for Latin America, Middle East, Africa and Asia where he led a -multi-functional team of marketing, sales and government affairs professionals generating two third of the group’s vaccine revenue. While at J&J Yves Leurquin organized the development and international launch of the first liquid Penta vaccine, winning supply contracts with UNICEF and PAHO and rapidly achieving a dominant market share. Prior to joining Johnson &Johnson, Yves was with the vaccine division of GlaxoSmithKline, holding progressively responsible positions over a 10-year tenure.

Links

Previous companies

Crucell N.V. logo
Honeywell logo
Takeda Pharmaceutical logo
DuPont logo
Siemens logo
Carrefour logo

Timeline

  • Co-CEO

    Current role

View in org chart